Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines

Author: Collins D.   Crown J.   O’Donovan N.   Devery A.   O’Sullivan F.   O’Driscoll L.   Clynes M.   O’Connor R.  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.28, Iss.4, 2010-08, pp. : 433-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract